“It's a colon medicine, the doctor told me to take it for a while.” Many people know Dogmatil this way, and are surprised to read the word “schizophrenia” in the leaflet. This guide explains the truth about this medication: what it is, why it is prescribed for conditions that seem far apart, and which harms deserve attention, especially with long-term use.
What is Dogmatil?
Dogmatil is a brand name for sulpiride, available in Egypt in two strengths under the names Dogmatil and Dogmatil Forte. It is a relatively old psychiatric drug belonging to the group of substituted benzamides, which are antipsychotics that selectively block D2 and D3 dopamine receptors, with little effect on histamine or acetylcholine.
Why is Dogmatil prescribed?
According to the product label approved in the UK, the approved use of sulpiride is treating acute and chronic schizophrenia at relatively high doses. At low doses it is thought to block mainly the receptors that restrain dopamine release, so its effect is a mild mood-lifting one. That is why it is prescribed in Egypt and other countries for conditions such as:
- Anxiety and tension accompanied by physical symptoms, as in psychosomatic disorders.
- Functional stomach and colon symptoms linked to psychological stress.
- Some cases of mild depression, as an add-on treatment.
Harms and side effects of Dogmatil
Breast enlargement and discharge, reduced desire and erections, and menstrual irregularity in women.
Increased appetite and weight with continued use.
Tremor, stiffness and restlessness, and tardive dyskinesia with long-term use.
Varies from person to person depending on the dose.
It may prolong the QT interval and raise the risk of rhythm disturbances.
Rare: fever, stiffness and confusion that call for emergency care.

Raised prolactin deserves special attention in men, because it may appear as sexual dysfunction or breast enlargement that is wrongly put down to other causes. If you notice this during treatment, tell your doctor instead of stopping the medication or looking for a treatment for the symptoms alone.
Who should avoid Dogmatil or take precautions with it?
- Prolactin-dependent tumors, such as pituitary tumors and breast cancer.
- Pheochromocytoma, a tumor of the adrenal gland.
- People taking levodopa or Parkinson's disease medications.
- Impaired kidney function, because the kidneys are its main route out of the body.
- Heart disease, a slow pulse or low potassium, or taking drugs that prolong the QT interval.
- Older adults, especially those with dementia.
- Pregnancy and breastfeeding: decided with the doctor only.
Dogmatil interactions
The product label states that alcohol should be avoided because it increases the sedative effect, and that it should not be combined with levodopa because each cancels the effect of the other. Caution is needed with heart drugs that slow the pulse, diuretics that lower potassium, some antibiotics and other antipsychotics that prolong the QT interval, and with sedatives and tramadol, which increase drowsiness.
Is Dogmatil addictive? And symptoms of stopping it
Dogmatil does not cause addiction or euphoria. But the product label notes that stopping antipsychotics suddenly can cause nausea, vomiting, sweating and insomnia, and the original symptoms may return or involuntary movements may appear, which is why gradual discontinuation is advised. For someone who has used it for months for anxiety or colon symptoms and wants to stop, it is best to see the doctor to draw up a gradual plan and an alternative treatment for the underlying cause.
When should you see the doctor?
See the doctor if you notice breast discharge or enlargement, sexual dysfunction, tremor and stiffness, palpitations and fainting, or fever with stiffness and confusion. If anxiety or physical symptoms persist despite the medication, you may need a comprehensive psychiatric assessment. At Eradah Hospital, your full medication history is reviewed within a plan that includes anxiety treatment with psychological therapy and the most suitable medication, usually in the outpatient clinics.